Showing 6561-6570 of 23150 results for "".
Evaluating Obscure GI Bleeding
https://reachmd.com/programs/gi-insights/evaluating-obscure-gi-bleeding/5972/Obscure gastrointesinal bleeding can pose investigational challenges. What are the potential causes of obscure GI bleeding? After initial negative upper endoscopy and colonoscopy tests are performed, what new technologies can help physicians more effectively detect small bowel abnormalities? Dr. JonWhen PPIs Fail: Evaluating and Managing Patients with Refractory GERD
https://reachmd.com/programs/gi-insights/when-ppis-fail-evaluating-and-managing-patients-with-refractory-gerd/5968/Resistance to proton pump inhibitors, or PPIs, is not uncommon among patients with gastroesophogeal reflux disease, or GERD. How should physicians initially approach managing patients with suspected GERD, and at what point should physicians classify a patient as a PPI non-responder? Our guest, Dr. BPregnancy and Heart Disease: Minimizing Risks
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/pregnancy-and-heart-disease-minimizing-risks/5681/How can physicians assess and minimize the risk for women with existing heart disease prior to pregnancy? As many women are waiting longer to become pregnant, is the spectrum of cardiovascular disease among pregnant women changing as well? Dr. Nazanin Moghbeli, founder and director of the Women's CaCancer and End-of-Life Issues in the Emergency Department
https://reachmd.com/programs/focus-on-cancer/cancer-and-end-of-life-issues-in-the-emergency-department/4341/More than 500,000 Americans die from cancer every year, and many of those people spend their final hours in the emergency department. More and more patients and their families turn to ED doctors to help make difficult decisions when it comes to end-of-life issues. Dr. Arthur Derse, director of medicA Look Back at Pharmacy Practice Over the Years
https://reachmd.com/programs/focus-on-pharmacy/a-look-back-at-pharmacy-practice-over-the-years/4092/The practice of pharmacy has certainly changed over the years, with pharmacy schools and pharmacists making an effort to become more patient-centered. Still, sometimes it takes a retrospective look through the eyes of a healthcare professional who experienced those changes as they happened, to trulyDrug-Induced Liver Injury
https://reachmd.com/programs/gi-insights/drug-induced-liver-injury/4058/Acetaminophen, vitamin supplements and antibiotics are just a few of the medications that can cause liver injury. What are the signs of drug-induced liver injury? Are the effects immediate, or do the effects become noticeable after an extended period of time? Dr. Rowen Zetterman, professor of internGrapefruit Juice and Drug Metabolism
https://reachmd.com/programs/clinicians-roundtable/grapefruit-juice-and-drug-metabolism/2357/More than 40 drugs have been demonstrated to interact with grapefruit juice, primarily drugs that are first-pass metabolized. Join host Dr. Larry Kaskel and guest Dr. David Baily to discuss the serious nature of potential grapefruit juice/drug interactions and how best to communicate the required caContrasts Between Hospital and Office EMRs
https://reachmd.com/programs/clinicians-roundtable/contrasts-between-hospital-and-office-emrs/2264/Many doctors complain about their hospital's EMR. It is combersome and not intuitive. Yet the government wants doctors to introduce the electronic medical record to their offices. Are EMR's for doctor offices as difficult to use as their larger, more ambitious hospital brethren? Our guest today is JPredictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study
https://reachmd.com/programs/Audioabstracts/predictors-emergency-department-use-persons-with-inflammatory-bowel-diseases-population-based-study/8566/Identified predictors of ED attendance and post-ED hospitalization could guide the optimization of outpatient IBD care.Risk Stratification Models for Precursor Diseases in Multiple Myeloma
https://reachmd.com/programs/project-oncology/risk-stratification-models-for-precursor-diseases-in-multiple-myeloma/26581/Learn about the current risk stratification models for precursor diseases in multiple myeloma and how we may be able to optimize them in the future.